PLoS Pathogens (Jan 2024)

Late-rising CD4 T cells resolve mouse cytomegalovirus persistent replication in the salivary gland.

  • Simon Brunel,
  • Gaelle Picarda,
  • Ankan Gupta,
  • Raima Ghosh,
  • Bryan McDonald,
  • Rachid El Morabiti,
  • Wenjin Jiang,
  • Jason A Greenbaum,
  • Barbara Adler,
  • Gregory Seumois,
  • Michael Croft,
  • Pandurangan Vijayanand,
  • Chris A Benedict

DOI
https://doi.org/10.1371/journal.ppat.1011852
Journal volume & issue
Vol. 20, no. 1
p. e1011852

Abstract

Read online

Conventional antiviral memory CD4 T cells typically arise during the first two weeks of acute infection. Unlike most viruses, cytomegalovirus (CMV) exhibits an extended persistent replication phase followed by lifelong latency accompanied with some gene expression. We show that during mouse CMV (MCMV) infection, CD4 T cells recognizing an epitope derived from the viral M09 protein only develop after conventional memory T cells have already peaked and contracted. Ablating these CD4 T cells by mutating the M09 genomic epitope in the MCMV Smith strain, or inducing them by introducing the epitope into the K181 strain, resulted in delayed or enhanced control of viral persistence, respectively. These cells were shown to be unique compared to their conventional memory counterparts; producing higher IFNγ and IL-2 and lower IL-10 levels. RNAseq analyses revealed them to express distinct subsets of effector genes as compared to classical CD4 T cells. Additionally, when M09 cells were induced by epitope vaccination they significantly enhanced protection when compared to conventional CD4 T cells alone. These data show that late-rising CD4 T cells are a unique memory subset with excellent protective capacities that display a development program strongly differing from the majority of memory T cells.